Interesting facts
Interesting Facts about 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
This compound, known as 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide, is a fascinating example of a synthetic organic molecule with notable applications in medicinal chemistry. Here are some engaging facts about this intriguing compound:
- Pharmaceutical Potential: Compounds of this structure are often explored for their therapeutic properties. They may exhibit pharmacological activities making them valuable in drug development.
- Structure Activity Relationship (SAR): The unique arrangement of functional groups within this molecule allows researchers to study how small changes in structure affect biological activity, which is critical in the field of medicinal chemistry.
- Synthesis Challenges: The synthesis of complex amides like this one can present challenges. Organic chemists must carefully select conditions to preserve the integrity of the piperidine and phenyl moieties while ensuring high yields.
- Research Significance: As our understanding of neurological and psychological disorders advances, compounds that can influence neurotransmitter systems, such as this one, may emerge as potential therapeutics.
- Analytical Techniques: Characterizing compounds like this often involves sophisticated analytical techniques including NMR spectroscopy and mass spectrometry, which provide insight into molecular structure and purity.
- Structure Variability: The presence of bulkier substituents, such as the 2,6-dimethylphenyl group, can significantly impact the compound's interactions with biological targets, leading to variations in potency and efficacy.
The exploration of molecules like 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide showcases the delicate interplay between structure, function, and biological activity, making it an area of great interest for current and future chemists.
Synonyms
bupivacaine
2180-92-9
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
38396-39-3
DL-Bupivacaine
Marcaine
Bupivacaina
Anekain
Bupivacainum
(+-)-Bupivacaine
Sensorcaine
1-Butyl-2',6'-pipecoloxylidide
Bucaine
Bupivacainum [INN-Latin]
Bupivacaina [INN-Spanish]
dl-1-Butyl-2',6'-pipecoloxylidide
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-
Win 11318
AH 250
Exparel
Posimir
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
Bloqueina
SKY0402
(+/-)-Bupivacaine
2',6'-Pipecoloxylidide, 1-butyl-
1-butyl-N-(2,6-dimethylphenyl)-piperidine-2-carboxamide
EINECS 218-553-3
EINECS 253-911-2
Marcain
LIQ865
UNII-Y8335394RO
CHEBI:77431
HSDB 7790
LIQ-865
SKY 0402
SKY-0402
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
Y8335394RO
CHEBI:3215
DTXSID2022703
Xaracoll
ZYNRELEF COMPONENT BUPIVACAINE
LAC-43
cBupivacaine
Bupivacainum (INN-Latin)
Bupivacaina (INN-Spanish)
Bupivacaine HCL KIT
bupivacaine base
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (+/-)-
Bucaine (TN)
Bupivacaine Solution in Acetonitrile, 100ug/mL
DUR-843
(r)-(+)-Bupivacaine hcl
14252-80-3 (HCl)
73360-54-0 (HCl.H2O)
Nocita
Bupivacaine [USAN:INN:BAN]
racemic bupivacaine
(RS)-bupivacaine
Bupivacaine liposome
Exparel (TN)
Liposomal bupivacaine
MFCD00243007
Bupivacaine Free Base
Spectrum_001524
Bupivacaine liposome injectable suspension
Marcaine and Sensorcaine
BUPIVACAINE [MI]
Prestwick0_000305
Prestwick1_000305
Prestwick2_000305
Prestwick3_000305
Spectrum2_001589
Spectrum3_000974
Spectrum4_001098
Spectrum5_001483
BUPIVACAINE [INN]
(.+/-.)-1-Butyl-2',6'-pipecoloxylidide
(.+/-.)-Bupivacaine
Bupivacaine (USAN/INN)
BUPIVACAINE [HSDB]
BUPIVACAINE [USAN]
LAC-43 (Salt/Mix)
Epitope ID:122662
BUPIVACAINE [VANDF]
Marcaine spinal (Salt/Mix)
CHEMBL1098
SCHEMBL25438
BSPBio_000270
BSPBio_002607
BUPIVACAINE [WHO-DD]
KBioGR_001516
KBioSS_002004
DivK1c_000758
SPBio_001558
SPBio_002489
Bupivacaine; (RS)-bupivacaine
BPBio1_000298
Bupivacaine HCl Collagen-matrix
DTXCID802703
GTPL2397
BUPIVACAINE [GREEN BOOK]
KBio1_000758
KBio2_002004
KBio2_004572
KBio2_007140
KBio3_001827
BUPIVACAINE [ORANGE BOOK]
N01BB01
NINDS_000758
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboximidic acid
HMS2090F12
HMS3428P06
Marcaine hydrochloride (Salt/Mix)
BCP12242
BCP21825
HY-B0405
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (+-)-
BDBM50350790
BR-003
MFCD00941462
STL484283
AKOS001637202
AKOS016842516
MSK11353-100A
AC-2096
BS-5224
CS-W023182
DB00297
FB61551
BUPIVACAINE COMPONENT OF ZYNRELEF
IDI1_000758
NCGC00178579-01
NCGC00178579-02
BB166160
1ST11353-100A
SBI-0051846.P002
18010-40-7 (HCl)
DB-119016
AB00053674
NS00000609
C07529
D07552
Ropivacaine hydrochloride impurity, bupivacaine-
AB00053674-08
AB00053674-09
AB00053674_10
AB00053674_11
EN300-18292932
L000695
Q422806
BRD-A01636364-003-05-2
BRD-A01636364-003-08-6
BRD-A01636364-003-14-4
BRD-A01636364-003-15-1
(plusmn)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
1-Butyl-N-(2 pound not6-dimethylphenyl)piperidine-2-carboxamide
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (.+/-.)-
ROPIVACAINE HYDROCHLORIDE IMPURITY, BUPIVACAINE- [USP IMPURITY]
119427-31-5
218-553-3
Solubility of 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide (C18H28N2O)
The solubility of 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide exhibits several interesting characteristics influenced by its molecular structure:
Overall, it can be stated that:
Understanding the solubility of this compound is crucial for its application in various fields, as it directly impacts its biological activity and formulation in pharmaceutical solutions.